Blackstone and TPG on the Verge of Sealing $17 Billion Hologic Acquisition Deal
Blackstone Inc. and TPG Inc. are reportedly nearing an agreement to acquire Hologic Inc. for over $17 billion, including debt. Sources close to the situation indicate that the two private equity firms are in advanced talks and a deal could be announced soon.
Details of the Potential Acquisition
Negotiations currently center around a share price exceeding $75. This potential acquisition has sparked interest in the stock market, as Hologic’s shares increased by approximately 6% during late trading after the news broke. On the previous Friday, the shares had closed at $69.85, bringing the company’s market capitalization to around $15.5 billion.
Status of the Negotiations
It is important to note that a final agreement has yet to be made. The talks are ongoing and could ultimately collapse. Representatives from both Blackstone and TPG, along with officials from Hologic based in Marlborough, Massachusetts, have declined to comment on the situation.
Background on Hologic Inc.
Hologic specializes in medical devices with a strong focus on women’s health. The company develops diagnostic solutions for various health concerns, including:
- Breast cancer
- Cervical cancer
- Infectious diseases, including COVID-19
If finalized, this acquisition may mark one of the largest private equity takeovers of the year, according to data from Bloomberg. The interest from Blackstone and TPG underscores the significant value they see in Hologic’s operations and market position.
